{
    "Trade/Device Name(s)": [
        "LeadCare Ultra Blood Lead Testing System",
        "LeadCare Ultra Blood Lead Testing System",
        "LeadCare\u00ae Ultra\u2122 Blood Lead Testing System"
    ],
    "Submitter Information": "Magellan Diagnostics, Inc.",
    "510(k) Number": "K123563",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052549"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DOF"
    ],
    "Summary Letter Date": "August 20, 2013",
    "Summary Letter Received Date": "July 11, 2013",
    "Submission Date": "July 10, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3550"
    ],
    "Regulation Name(s)": [
        "Lead test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Lead"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Micro-capillary tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LeadCare Ultra Analyzer",
        "Dedicated computer workstation"
    ],
    "Method(s)/Technology(ies)": [
        "Anodic Stripping Voltammetry (ASV)",
        "Electrochemistry"
    ],
    "Methodologies": [
        "Quantitative analysis"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Kit",
        "Sensor",
        "Control",
        "Calibration Button"
    ],
    "Document Summary": "FDA 510(k) summary for LeadCare Ultra Blood Lead Testing System for quantitative measurement of lead in whole blood using electrochemical detection.",
    "Indications for Use Summary": "Quantitative measurement of lead in whole blood samples for prescription use in vitro only; not intended for point of care use.",
    "fda_folder": "Toxicology"
}